Conatus Pharmaceuticals Inc. (CNAT)

[fishhunter]

Upcoming catalysts:

1. Start of last remaining Ph2 trial. For sure in Q2, likely in April or May.

2. Novartis signing the option. The "trigger" to sign is the start of the last remaining Ph2 trial. "Trigger" is a direct quote from Conatus CEO Mentos.

Then there are many catalysts later in 2017 and throughout 2018. 2017 will have some big milestone payments. 2018 will have even bigger milestone payments based on the trial results as they are announced.